News

Astria Therapeutics to Showcase Breakthrough Data at EADV

Astria Therapeutics to Showcase Breakthrough Data at EADV

Astria Therapeutics to Present at EADV Congress

Astria Therapeutics, Inc. (NASDAQ: ATXS), an innovative biopharmaceutical firm, is thrilled to share its plans to participate in the esteemed European Academy of Dermatology and Venereology (EADV) Congress. This notable event will be held in Amsterdam, where fresh ideas and cutting-edge research come together.

Presentation Details

This important congress is set for September 26, 2024, during which Astria Therapeutics will present early data from their ALPHA-STAR study. This trial plays a crucial role in examining the safety and effectiveness of navenibart (STAR-0215), a treatment specifically aimed at managing hereditary angioedema.

The Role of Dr. Raffi Tachdjian

Dr. Raffi Tachdjian, an esteemed Associate Clinical Professor of Medicine and Pediatrics with a focus on Allergy and Clinical Immunology at UCLA, will lead the presentation. He’ll share key findings from the Phase 1b/2 clinical trial in his poster titled, “ALPHA-STAR, a Phase 1b/2 Clinical Trial of Single and Multiple Doses of STAR-0215 in Patients with Hereditary Angioedema: Initial Safety and Efficacy Outcomes.”

A Deep Dive into ALPHA-STAR Data

The poster presentation is scheduled for the e-poster showcase session on the afternoon of September 26, offering attendees a chance to explore initial results related to the safety and efficacy of STAR-0215. This trial is designed to enhance our understanding of possible treatments for patients struggling with hereditary angioedema.

About Astria Therapeutics

Astria Therapeutics is committed to changing the lives of patients and families affected by allergic and immunologic diseases. Their leading program, navenibart (STAR-0215), is making strides in clinical trials as a monoclonal antibody that targets plasma kallikrein. This innovative strategy is expected to significantly improve the management of hereditary angioedema.

Innovative Therapeutics in Development

Alongside STAR-0215, the company is also working on STAR-0310, another monoclonal antibody designed to block OX40. This program is currently in its preclinical phases, focusing on the treatment of atopic dermatitis. Astria Therapeutics remains dedicated to addressing the urgent needs of those affected by these conditions.

Join Us in Amsterdam

We invite anyone interested in dermatology and therapeutic advancements to attend the EADV Congress. The insights shared by Dr. Tachdjian and other key figures in the field promise to offer valuable knowledge for professionals and stakeholders alike.

Frequently Asked Questions

What is the EADV Congress?

The EADV Congress is a major event that highlights the latest advancements in dermatology, attracting researchers and clinicians from across the globe.

Who will present at the congress?

Dr. Raffi Tachdjian from UCLA will deliver a presentation on important findings regarding navenibart during the event.

What is navenibart?

Navenibart (STAR-0215) is a monoclonal antibody currently being studied for its effectiveness in treating hereditary angioedema.

What is hereditary angioedema?

Hereditary angioedema is a genetic disorder that results in recurrent episodes of severe swelling in various areas of the body.

Can I learn more about Astria Therapeutics?

Absolutely! You can find additional information about the company and its groundbreaking therapies by visiting their official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AI Use Hits 93% in Health Systems' Digital Shift

Updated Category News Views 33

Healthcare's AI Surge: Jumping the Adoption Hurdle The digital health landscape isn't just humming along—it's hitting high gear. AI, once the shiny toy in innovation's toolkit, is now a fixture in 93.2% of healthcare systems according to CHIME's latest findings. For anyone keeping score, that's a hefty leap and paints a picture where AI isn't just in the game, it's...

Continue Reading
Dana Concludes Tender Offers for Senior Notes

Updated Category News Views 72

An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...

Continue Reading
Later's NYC Summit Reinvents Social Commerce Game Plan

Updated Category News Views 120

Creators and Corporates Collide Imagine this: an NYC stage not adorned with Broadway's finest, but with digital maestros steering a new age in social commerce. That's what Later is betting on with their Creator Live summit, debuting in the bustling heart of New York City. We're talking about influencers not just as Instagram stars, but as key players in a $480 billion...

Continue Reading
Koppers Faces SEC Scrutiny After Earnings Miss

Updated Category News Views 124

Koppers' Third-Quarter Blues: Missing the Mark Koppers Holdings Inc. (NYSE: KOP) took a hard hit this quarter, missing Wall Street's earnings expectations by a mile. The adjusted earnings per share came in at just $0.77, while the suits down on Wall Street were expecting something closer to $1.34 to $1.37. Now, if you’re holding KOP in your portfolio, you're probably...

Continue Reading
National Police Assoc. Urges House to Pass PTSD Act

Updated Category News Views 101

An Urgent Call for Action on PTSD Support Alright folks, this ain't your typical investment rundown, but it's got stakes just the same. The National Police Association is sounding the horn for the House to pass the Fighting Post-Traumatic Stress Disorder Act of 2025 (S. 825). Now, if you've been around the block, you know legislation can play out like a market...

Continue Reading
CR&R Workers Join Teamsters, Fight for Fair Conditions

Updated Category News Views 74

Waste Workers Push Back Against Corporate Pressure The Southern California sun isn't the only thing heating up these days; the waste workers at CR&R Environmental Services have cranked up the heat by voting to join Teamsters Local 396. It's like Groundhog Day in the world of labor rights—same story, different locale, workers banding together for a fair shot. A Stand...

Continue Reading
SOCSA: The Future of Safety in Confined Spaces?

Updated Category News Views 68

Autonomous Tech Meets Safety Regulations Some days innovation hits like a ton of bricks, and here we go again—this time with a gizmo aiming to shake up the safety game in confined spaces. Enter the SOCSA, the Self Operating Confined Space Attendant, designed by a seasoned agriculture worker who's had a ringside seat to enough OSHA rule breaches to fill a book. But ain't...

Continue Reading
Accuray Finishes Key Deal, Resetting Financial Trajectory

Updated Category News Views 112

Accuray Secures the Deal, But Is the Future Bright? Every now and then in the investing world, a company pulls off a maneuver that you wish you’d thought of first. Today, folks, it's Accuray's turn. They've just wrapped up a monstrous transaction with TCW – their primary lender and shareholder – that has them feeling optimistic about the road ahead. Bold Moves to...

Continue Reading
Citigroup, Scotia Aid TSTT in $500M Note Offering

Updated Category News Views 49

Kicking off with a banger that’s got financial water coolers buzzing, Greenberg Traurig just pulled a rabbit out of the hat helping Citigroup and Scotia Capital orchestrate a chunky near $500 million dual-currency notes deal for Telecommunications Services of Trinidad and Tobago Limited (TSTT). Now, this isn’t your run-of-the-mill market maneuver. We're seeing a...

Continue Reading
Agiloft Navigates New Growth Phase with Key Leadership

Updated Category News Views 142

Leadership Shifts Steer Agiloft's EMEA Journey Agiloft's latest shake-ups in leadership signal a determined charge through EMEA's bustling markets. Nick Bowles, a seasoned veteran in enterprise software, steps into the limelight as Senior Vice President, while Jim Leason shifts gears into a customer-focused advisory role. These aren’t just routine hiring...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating 30 Years: Feminist Leaders Forge a New Path

Updated Category News Views 129

Feminist Leaders Gather for a New Chapter in Feminism An inspiring gathering of feminist trailblazers explored the future of feminist strategies, narrative power, and the evolution of feminist media. Reflecting on Feminism's Growth Feminist.com recently commemorated its impressive three-decade journey with a special salon hosted in the iconic home of Gloria Steinem, a key...

Continue Reading
Scott Bessent's Strategic Shift: What Comes Next for Bitcoin?

Updated Category News Views 150

U.S. Treasury's New Direction on Bitcoin Acquisitions U.S. Treasury Secretary Scott Bessent has recently shared important updates regarding the government's stance on Bitcoin holdings. During a public statement, Bessent clarified that the government will no longer be acquiring additional Bitcoin for its strategic reserve. Instead, he stated that the only way the holdings...

Continue Reading
Sensus Healthcare Faces Legal Scrutiny Amid Declining Revenue

Updated Category News Views 184

Understanding the Current Situation of Sensus Healthcare Sensus Healthcare, Inc. has recently attracted the attention of legal experts as the company navigates through troubling financial results. This examination is critical for stockholders who may be wondering about their investment’s future. Established in the healthcare sector, the company specializes in innovative...

Continue Reading
Market Gains on Micron's Surge and China’s Stimulus Moves

Updated Category News Views 165

Micron, Inc. (NASDAQ: MU) has sparked quite the buzz on Wall Street following its recent earnings announcement. The report didn’t just meet expectations; it lit a fire under the stock, which surged over 15% in premarket trading. This performance signals a potential shift in market momentum that traders have been eagerly awaiting. The global markets seem to be catching...

Continue Reading
MetaRouter Appoints Nikhil Raj as New CEO for AI-Driven Growth

Updated Category News Views 285

MetaRouter Announces Nikhil Raj as New CEO MetaRouter, a leader in enterprise-grade customer data infrastructure, recently announced the appointment of Nikhil Raj as its new Chief Executive Officer. This move marks an important transition for the company as it embarks on its upcoming growth phase, aimed at empowering businesses to navigate the complexities of AI...

Continue Reading